Cost-effectiveness of telehealth for patients with raised cardiovascular disease risk: evidence from the Healthlines randomised controlled trial
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Objectives: To investigate the cost-effectiveness of a telehealth intervention for primary care patients with raised cardiovascular disease (CVD) risk. Design: A prospective within-trial patient-level economic evaluation conducted alongside a randomised controlled trial. Setting: Patients recruited through primary care, and intervention delivered via telehealth service. Participants: Adults with a 10-year CVD risk ≥20%, as measured by the QRISK2 algorithm, with at least 1 modifiable risk factor. Intervention: A series of up to 13 scripted, theory-led telehealth encounters with healthcare advisors, who supported participants to make behaviour change, use online resources, optimise medication and improve adherence. Participants in the control arm received usual care. Primary and secondary outcome measures: Cost-effectiveness measured by net monetary benefit at the end of 12 months of follow-up, calculated from incremental cost and incremental quality-adjusted life years (QALYs). Productivity impacts, participant out-of-pocket expenditure and the clinical outcome were presented in a cost-consequences framework. Results: 641 participants were randomised—325 to receive the telehealth intervention in addition to usual care and 316 to receive only usual care. 18% of participants had missing data on either costs, utilities or both. Multiple imputation was used for the base case results. The intervention was associated with incremental mean per-patient National Health Service (NHS) costs of £138 (95% CI 66 to 211) and an incremental QALY gain of 0.012 (95% CI −0.001 to 0.026). The incremental cost-effectiveness ratio was £10 859. Net monetary benefit at a cost-effectiveness threshold of £20 000 per QALY was £116 (95% CI −58 to 291), and the probability that the intervention was cost-effective at this threshold value was 0.77. Similar results were obtained from a complete case analysis. Conclusions: There is evidence to suggest that the Healthlines telehealth intervention was likely to be cost-effective at a threshold of £20 000 per QALY. Trial registration number: ISRCTN27508731; Results. Prospectively registered 05 July 2012.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795 · cited 1×
“Participants responded to questions concerning health-related quality of life at baseline and at 6 and 12 months postrandomisation using the EQ-5D-5L measure.(19) This generic instrument measures five dimensions (mobility, self-care, usual activities, pain and”
MethodHeidenreich, P. A., Trogdon, J. G., Khavjou, O. A., Butler, J., Dracup, K., Ezekowitz, M. D., Finkelstein, E. A., Hong, Y., Johnston, S. C., Khera, A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820a55f5 · Cited by 3,208
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., Loder, E., et al. (2013) · BMJ · doi:10.1136/bmj.f1049 · Cited by 1,776
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Hippisley-Cox, J., Coupland, C., Vinogradova, Y., Robson, J., Minhas, R., Sheikh, A., & Brindle, P. (2008) · BMJ · doi:10.1136/bmj.39609.449676.25 · Cited by 1,459
Multiple Imputation by Chained Equations (MICE): Implementation in Stata
Royston, P., & White, I. (2011) · Journal of Statistical Software · doi:10.18637/jss.v045.i04 · Cited by 1,248
Manca, A., Hawkins, N., & Sculpher, M. J. (2005) · Health Economics · doi:10.1002/hec.944 · Cited by 1,024
Review of statistical methods for analysing healthcare resources and costs
Mihaylova, B., Briggs, A., O'Hagan, A., & Thompson, S. G. (2011) · Health Economics · doi:10.1002/hec.1653 · Cited by 767 · cited 1×
“The cost-effectiveness analysis used seemingly unrelated regression (SUR), for which we rely on the near normality of differences in sample means and differences in sample variances in large samples.(31) 32 We implemented SUR using the—sureg—command in”
MethodFaria, R., Gomes, M., Epstein, D., & White, I. R. (2014) · PharmacoEconomics · doi:10.1007/s40273-014-0193-3 · Cited by 673
Steventon, A., Bardsley, M., Billings, J., Dixon, J., Doll, H., Hirani, S., Cartwright, M., Rixon, L., Knapp, M., Henderson, C., et al. (2012) · BMJ · doi:10.1136/bmj.e3874 · Cited by 583 · cited 1×
“40–42 A notable example of cost-effectiveness analysis within an English NHS context of telehealth for longterm conditions was evaluation of the ‘Whole Systems Demonstrator’ (WSD) project.(43) 44 Patients with a long-term condition (heart failure, chronic obstructive pulmonary disease or diabetes) received either tele…”
BackgroundTwenty years of telemedicine in chronic disease management – an evidence synthesis
Wootton, R. (2012) · Journal of Telemedicine and Telecare · doi:10.1258/jtt.2012.120219 · Cited by 545
Cited by
Determining if Telehealth Can Reduce Health System Costs: Scoping Review
Snoswell, C. L., Taylor, M. L., Comans, T. A., Smith, A. C., Gray, L. C., & Caffery, L. J. (2020) · Journal of Medical Internet Research · doi:10.2196/17298 · Cited by 448
Telemedicine, COVID-19, and disparities: Policy implications
Ortega, G., Rodriguez, J. A., Maurer, L. R., Witt, E. E., Perez, N., Reich, A., & Bates, D. W. (2020) · Health Policy and Technology · doi:10.1016/j.hlpt.2020.08.001 · Cited by 258
Economic evaluations of eHealth technologies: A systematic review.
Sanyal, C., Stolee, P., Juzwishin, D., & Husereau, D. (2018) · PLOS ONE · doi:10.1371/journal.pone.0198112 · Cited by 77
Farabi, H., Rezapour, A., Jahangiri, R., Jafari, A., Rashki Kemmak, A., & Nikjoo, S. (2020) · Heart Failure Reviews · doi:10.1007/s10741-019-09864-4 · Cited by 41
Shantharam, S. S., Mahalingam, M., Rasool, A., Reynolds, J. A., Bhuiya, A. R., Satchell, T. D., Chapel, J. M., Hawkins, N. A., Jones, C. D., Jacob, V., et al. (2022) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.06.025 · Cited by 13
Metadata
- Authors
- Dixon, P., Hollinghurst, S., Edwards, L., Thomas, C., Gaunt, D., Foster, A., Large, S., Montgomery, A. A., & Salisbury, C.
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2016-08
- Volume
- 6
- Issue
- 8
- Pages
- e012352
- ISSN
- 2044-6055 (ISSN-L)
- OpenAlex
- W2506180733
- Cited by
- 39
- References
- 12
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-effectiveness of telehealth for patients with raised cardiovascular disease risk: evidence from the Healthlines randomised controlled trial. https://app.cochat.ai/papers/10.1136/bmjopen-2016-012352
- The paper
- Dixon, P., Hollinghurst, S., Edwards, L., Thomas, C., Gaunt, D., Foster, A., Large, S., Montgomery, A. A., & Salisbury, C. (2016). Cost-effectiveness of telehealth for patients with raised cardiovascular disease risk: evidence from the Healthlines randomised controlled trial. BMJ Open. https://doi.org/10.1136/bmjopen-2016-012352
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.